Brian W. Ellis
Net Worth
Last updated:
What is Brian W. Ellis net worth?
The estimated net worth of Mr. Brian W. Ellis is at least $77,998,144 as of 2 Feb 2022. He owns shares worth $24,957,256 as insider, has earned $22,160,888 from insider trading and has received compensation worth at least $30,880,000 in Danaher Corporation and Danaher Corporation.
What is the salary of Brian W. Ellis?
Mr. Brian W. Ellis salary is $1,930,000 per year as Senior Vice President, Gen. Counsel & Chief Compliance Officer in Danaher Corporation. He also receives $1,930,000 as Senior Vice President, Gen. Counsel & Chief Compliance Officer in Danaher Corporation.
How old is Brian W. Ellis?
Mr. Brian W. Ellis is 58 years old, born in 1967.
What stocks does Brian W. Ellis currently own?
As insider, Mr. Brian W. Ellis owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Danaher Corporation (DHR) | Senior Vice President, Gen. Counsel & Chief Compliance Officer | 20,230 | $212.53 | $4,299,482 |
| Danaher Corporation (DHR-PB) | Senior Vice President, Gen. Counsel & Chief Compliance Officer | 12,374 | $1,669.45 | $20,657,774 |
What does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
What does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Brian W. Ellis insider trading
Danaher Corporation
Mr. Brian W. Ellis has made 8 insider trades between 2017-2022, according to the Form 4 filled with the SEC. Most recently he sold 5,365 units of DHR-PB stock worth $1,577,246 on 2 Feb 2022.
The largest trade he's ever made was exercising 12,000 units of DHR-PB stock on 28 Jul 2021. As of 2 Feb 2022 he still owns at least 12,374 units of DHR-PB stock.
Danaher Corporation
Mr. Brian W. Ellis has made 11 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 9,600 units of DHR stock worth $2,641,536 on 25 Jul 2024.
The largest trade he's ever made was exercising 12,000 units of DHR stock on 28 Jul 2021. As of 2 Feb 2022 he still owns at least 20,230 units of DHR stock.
Danaher key executives
Danaher Corporation executives and other stock owners filed with the SEC:
- Mr. Brian W. Ellis (58) Senior Vice President, Gen. Counsel & Chief Compliance Officer
- Mr. Joakim Weidemanis (56) Executive Vice President
- Mr. Matthew R. McGrew (53) Chief Financial Officer & Executive Vice President
- Mr. Rainer M. Blair (61) Pres, Chief Executive Officer & Director
- Ms. Angela S. Lalor (60) Senior Vice President of HR